Veradigm (MDRX) Competitors

Omnicell (NASDAQ:OMCL) and Veradigm (NASDAQ:MDRX) are both small-cap health care technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

Do analysts recommend OMCL or MDRX?

Omnicell presently has a consensus price target of $45.33, suggesting a potential upside of 46.10%. Veradigm has a consensus price target of $13.00, suggesting a potential upside of 177.78%. Given Veradigm's higher probable upside, analysts clearly believe Veradigm is more favorable than Omnicell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
Veradigm	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more risk and volatility, OMCL or MDRX?

Omnicell has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Veradigm has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500.

Which has stronger valuation and earnings, OMCL or MDRX?

Omnicell has higher earnings, but lower revenue than Veradigm.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.11B	1.31	$12.53M	$0.50	62.06
Veradigm	$1.53B	0.33	N/A	N/A	N/A

Is OMCL or MDRX more profitable?

Omnicell has a net margin of 2.01% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 4.27% beat Veradigm's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	2.01%	4.27%	2.44%
Veradigm	N/A	N/A	N/A

Do institutionals and insiders have more ownership in OMCL or MDRX?

97.7% of Omnicell shares are owned by institutional investors. 2.5% of Omnicell shares are owned by company insiders. Comparatively, 2.3% of Veradigm shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the media refer more to OMCL or MDRX?

In the previous week, Omnicell had 6 more articles in the media than Veradigm. MarketBeat recorded 7 mentions for Omnicell and 1 mentions for Veradigm. Omnicell's average media sentiment score of 0.60 beat Veradigm's score of 0.00 indicating that Omnicell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veradigm	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Omnicell beats Veradigm on 11 of the 13 factors compared between the two stocks.